Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart
Top Cited Papers
- 25 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (7) , 984-991
- https://doi.org/10.1161/01.cir.0000051865.66123.b7
Abstract
Background— The progression of compensated hypertrophy to heart failure (HF) is still debated. We investigated patients with isolated valvular aortic stenosis and differing degrees of left ventricular (LV) systolic dysfunction to test the hypothesis that structural remodeling, as well as cell death, contributes to the transition to HF. Methods and Results— Structural alterations were studied in LV myectomies from 3 groups of patients (group 1: ejection fraction [EF] >50%, n=12; group 2: EF 30% to 50%, n=12; group 3: EF 1 were upregulated correlating with fibrosis, which increased 2.3-, 2.2-, and 3.2-fold over control in the 3 groups. Myocyte degeneration increased 10, 22, and 32 times over control. A significant correlation exists between EF and myocyte degeneration or fibrosis. Ubiquitin-related autophagic cell death was 0.5‰ in control and group 1, 1.05 in group 2, and 6.05‰ in group 3. Death by oncosis was 0‰ in control, 3‰ in group 1, and increased to 5‰ (groups 2 and 3). Apoptosis was not detectable in control and group 3, but it was present at 0.02‰ in group 1 and 0.01‰ in group 2. Cardiomyocyte mitosis was never observed. Conclusions— These structure-function correlations confirm the hypothesis that transition to HF occurs by fibrosis and myocyte degeneration partially compensated by hypertrophy involving DNA synthesis and transcription. Cell loss, mainly by autophagy and oncosis, contributes significantly to the progression of LV systolic dysfunction.Keywords
This publication has 19 references indexed in Scilit:
- Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heartProceedings of the National Academy of Sciences, 2001
- The extracellular matrix in normal and diseased myocardiumJournal of Nuclear Cardiology, 2001
- Induction of Cardiac Fibrosis by Transforming Growth Factor-β1Molecular Genetics and Metabolism, 2000
- Unresolved Issues Regarding the Role of Apoptosis in the Pathogenesis of Ischemic Injury and Heart FailureJournal of Molecular and Cellular Cardiology, 2000
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJournal of the American College of Cardiology, 2000
- The Nomenclature of Cell Death: Recommendations of an ad hoc Committee of the Society of Toxicologic PathologistsToxicologic Pathology, 1999
- Regeneration processes in human myocardium after acute ischaemia ?quantitative determination of DNA, cell number and collagen contentVirchows Archiv, 1997
- Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblastsMolecular and Cellular Biochemistry, 1996
- The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.The Journal of cell biology, 1993
- The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3' splice site.Proceedings of the National Academy of Sciences, 1992